Lourens, Shantaily http://orcid.org/0000-0001-7603-1290
Van Deun, Laura
Peeters, Ilse
Paemeleire, Koen
Van Dycke, Annelies
De Klippel, Nina
Schoenen, Jean
Ritter, Shannon
Snellman, Josefin
Versijpt, Jan
Article History
Received: 2 January 2023
Accepted: 5 May 2023
First Online: 20 May 2023
Declarations
:
: Koen Paemeleire has received personal compensation from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Lundbeck and Teva for consulting, serving on a scientific advisory board, and/or speaking and is a clinical trial investigator for Amgen/Novartis (erenumab), Eli Lilly (galcanezumab), and Autonomic Technologies Inc. (sphenopalatine ganglion stimulation). Josefin Snellman has received personal compensation from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Lundbeck, Teva, Cefaly Technology, Autonomic Technologies Inc. and Man & Science for consulting, serving on a scientific advisory board, and/or speaking and is an investigator for Eli Lilly, Novartis, Lundbeck and Teva. Shannon Ritter and Josefin Snellman are full employees of Novartis. Jan Versijpt received personal fees and nonfinancial support from Teva, personal fees from Novartis and Lundbeck, and grants and nonfinancial support from Allergan/Abbvie.